Your Cart is Empty
Azelaic acid may help certain flat dark marks and uneven-looking pigmentation, especially when acne is part of the picture. Clinical research has evaluated specific 15% and 20% preparations. Brown marks, red marks and indented scars are different, so the first step is identifying which change you want to address.
| Appearance | Common description | What to keep in mind |
|---|---|---|
| Flat brown or gray-brown mark | Post-inflammatory hyperpigmentation, or PIH | Melanin-related discoloration after inflammation; deeper-looking pigment can be persistent. |
| Flat pink, red or dusky mark | Post-inflammatory erythema, or PIE | A vascular/inflammatory color change rather than simply excess melanin; appearance varies with skin tone. |
| Depression or raised area | A scar that changes texture | A topical pigment ingredient cannot be assumed to rebuild or flatten the scar. |
These features can overlap, and a photograph is not enough to diagnose every dark spot. A changing, irregular, bleeding or unexplained lesion should be assessed rather than treated as a routine acne mark.
Melanin is the pigment that contributes to skin color. Laboratory work has investigated azelaic acid's inhibition of tyrosinase, an enzyme involved in melanin production. That mechanism helps explain scientific interest in it for pigmentation.
Laboratory inhibition is not a prediction of how quickly a serum will fade a mark. Clinical response also depends on the cause, how deep the pigment sits, ongoing inflammation, sun exposure and the formulation used.
A randomized 2024 trial compared a 15% azelaic-acid gel with placebo for post-acne red and brown marks over 12 weeks and found improvement with the studied gel. A separate controlled trial evaluated 20% cream for facial hyperpigmentation in darker skin phototypes.
These are reasons to consider azelaic acid in an appropriate plan. They are not evidence that every cosmetic, derivative or combination produces the same result. They also do not establish a guarantee for all skin tones, all causes of pigmentation or indented scars.
Expect gradual assessment, not an overnight erase. The duration of a clinical trial is not a deadline by which every mark disappears. Compare photographs under consistent conditions and track whether new marks are still developing.
The timeline guide explains the difference between a study endpoint and an individual outcome. If a suitable routine is not helping, review the diagnosis and plan instead of simply increasing the percentage.
The ingredients have different clinical backgrounds and formulation issues. Use azelaic acid versus vitamin C, the alpha-arbutin comparison or the niacinamide comparison to choose by goal. A shared pigment-related mechanism does not establish that two ingredients are equivalent.
Melasma, sun-related spots and post-acne marks are not the same diagnosis. Persistent or recurrent pigmentation may need a clinician-directed plan. U.S. prescription labels also warn about isolated cases of unwanted lightening: report new pale patches rather than treating them as successful spot fading.
For the broader causes of discoloration, return to the hyperpigmentation guide. This article focuses on azelaic acid's evidence and practical role.
By Herbal Dynamics Beauty • September 26, 2026
